RantnerBGoebelGBonatiLHet al. The risk of carotid artery stenting compared with carotid endarterectomy is greatest in patients treated within 7 days of symptoms. J Vasc Surg. 2013;57:619–626.
2.
KakkosSKKakisisITsolakisIAet al. Endarterectomy achieves lower stroke and death rates compared with stenting in patients with asymptomatic carotid stenosis. J Vasc Surg. 2017;66:607–617.
3.
ParaskevasKIVeithFJ.Transcervical access, reversal of flow and mesh-covered stents: new options in the armamentarium of carotid artery stenting. World J Cardiol. 2017;9:416–421.
4.
TexakalidisPGiannopoulosSKokkinidisDGet al. Direct transcervical access vs the transfemoral approach for carotid artery stenting: a systematic review and meta-analysis. J Endovasc Ther. 2019;26:219–227.
5.
SfyroerasGSMoulakakisKGMarkatisFet al. Results of carotid artery stenting with transcervical access. J Vasc Surg. 2013;58:1402–1407.
6.
PowellRJSchermerhornMNolanBet al. Early results of carotid stent placement for treatment of extracranial carotid bifurcation occlusive disease. J Vasc Surg. 2004;39:1193–1199.
7.
LealIOrgazAFloresAet al. A diffusion-weighted magnetic resonance imaging-based study of transcervical carotid stenting with flow reversal versus transfemoral filter protection. J Vasc Surg. 2012;56:1585–1590.
8.
LinJCKolvenbachRRPinterL.Protected carotid artery stenting and angioplasty via transfemoral versus transcervical approaches. Vasc Endovascular Surg. 2005;39:499–503.
9.
MathieuXPiretVBergeronPet al. Choice of access for percutaneous carotid angioplasty and stenting: a comparative study on cervical and femoral access. J Cardiovasc Surg (Torino). 2009;50:677–681.
10.
PalomboGStellaNFaragliaVet al. Cervical access for filter-protected carotid artery stenting: a useful tool to reduce cerebral embolization. Eur J Vasc Endovasc Surg. 2010;39:252–257.
PlessersMVan HerzeeleIHemelsoetDet al. Perioperative embolization load and S-100β do not predict cognitive outcome after carotid revascularization. Ann Vasc Surg. 2016;36:175–181.
16.
MalasMBDakour-AridiHWangGJet al. Transcarotid artery revascularization versus transfemoral carotid artery stenting in the Society for Vascular Surgery Vascular Quality Initiative. J Vasc Surg. 2019;69:92–103.
17.
KwolekCJJaffMRLealJIet al. Results of the ROADSTER multicenter trial of transcarotid stenting with dynamic flow reversal. J Vasc Surg. 2015;62:1227–1234.
18.
ParaskevasKIMikhailidisDPVeithFJ.Mechanisms to explain the poor results of carotid artery stenting (CAS) in symptomatic patients to date and options to improve CAS outcomes. J Vasc Surg. 2011;53:837–844.
19.
CriadoEDoblasMFontcubertaJet al. Transcervical carotid stenting with internal carotid artery flow reversal: feasibility and preliminary results. J Vasc Surg. 2004;40:476–483.
KashyapVSKingAHFotehMIet al. A multi-institutional analysis of transcarotid artery revascularization compared to carotid endarterectomy [Published online January 6, 2019]. J Vasc Surg. doi:10.1016/j.jvs.2018.09.060
22.
MalasMBLeal LorenzoJINejimBet al. Analysis of the ROADSTER pivotal and extended-access cohort shows excellent 1-year durability of transcarotid stenting with dynamic flow reversal [published online January 2, 2019]. J Vasc Surg. doi:10.1016/j.jvs.2018.08.179.
23.
SchermerhornMLFokkemaMGoodneyPet al; SVS Outcomes Committee. The impact of Centers for Medicare and Medicaid Services high-risk criteria on outcome after carotid endarterectomy and carotid artery stenting in the SVS Vascular Registry. J Vasc Surg. 2013;57:1318–1324.